These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 24571489)
21. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Shapira A; Livney YD; Broxterman HJ; Assaraf YG Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184 [TBL] [Abstract][Full Text] [Related]
22. Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteria. Vaks L; Benhar I Methods Mol Biol; 2011; 726():187-206. PubMed ID: 21424451 [TBL] [Abstract][Full Text] [Related]
23. Bioinspired and Biomimetic Nanomedicines. Chen Z; Wang Z; Gu Z Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635 [TBL] [Abstract][Full Text] [Related]
24. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine. Lepeltier EA; Nuhn L; Lehr CM; Zentel R Nanomedicine (Lond); 2015; 10(20):3147-66. PubMed ID: 26447353 [TBL] [Abstract][Full Text] [Related]
25. Assembly, Engineering and Applications of Virus-Based Protein Nanoparticles. Mateu MG Adv Exp Med Biol; 2016; 940():83-120. PubMed ID: 27677510 [TBL] [Abstract][Full Text] [Related]
26. Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy. Duangrat R; Udomprasert A; Kangsamaksin T Cancer Sci; 2020 Sep; 111(9):3164-3173. PubMed ID: 32589345 [TBL] [Abstract][Full Text] [Related]
28. Nanomedicines functionalized with anti-EGFR ligands for active targeting in cancer therapy: Biological strategy, design and quality control. Nguyen PV; Allard-Vannier E; Chourpa I; Hervé-Aubert K Int J Pharm; 2021 Aug; 605():120795. PubMed ID: 34119579 [TBL] [Abstract][Full Text] [Related]
29. Silica based hybrid materials for drug delivery and bioimaging. Bagheri E; Ansari L; Abnous K; Taghdisi SM; Charbgoo F; Ramezani M; Alibolandi M J Control Release; 2018 May; 277():57-76. PubMed ID: 29550399 [TBL] [Abstract][Full Text] [Related]
30. Active targeting strategy in nanomedicines using anti-EGFR ligands - A promising approach for cancer therapy and diagnosis. Nguyen PV; Hervé-Aubert K; Chourpa I; Allard-Vannier E Int J Pharm; 2021 Nov; 609():121134. PubMed ID: 34571073 [TBL] [Abstract][Full Text] [Related]
31. Special issue of ChinaNanomedicine 2015. Shen Y Nanomedicine; 2016 Feb; 12(2):353. PubMed ID: 26711967 [TBL] [Abstract][Full Text] [Related]
32. Evaluating Nanomedicines: Obstacles and Advancements. Swierczewska M; Crist RM; McNeil SE Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088 [TBL] [Abstract][Full Text] [Related]
33. Biological and evolutionary concepts for nanoscale engineering: Viruses as natural nanoparticles have great potential for a wide range of nanoscale products. Steinmetz NF EMBO Rep; 2019 Aug; 20(8):e48806. PubMed ID: 31314151 [TBL] [Abstract][Full Text] [Related]
34. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead. Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062 [TBL] [Abstract][Full Text] [Related]
35. Engineering Virus Capsids Into Biomedical Delivery Vehicles: Structural Engineering Problems in Nanoscale. Bajaj S; Banerjee M J Biomed Nanotechnol; 2015 Jan; 11(1):53-69. PubMed ID: 26301300 [TBL] [Abstract][Full Text] [Related]
36. Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy. Shukla S; Hu H; Cai H; Chan SK; Boone CE; Beiss V; Chariou PL; Steinmetz NF Annu Rev Virol; 2020 Sep; 7(1):559-587. PubMed ID: 32991265 [TBL] [Abstract][Full Text] [Related]
38. Anticancer drug delivery with nanoparticles. Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748 [TBL] [Abstract][Full Text] [Related]
39. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine. Mohammadi M; Ramezani M; Abnous K; Alibolandi M Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259 [TBL] [Abstract][Full Text] [Related]
40. Protein-based nanomedicine platforms for drug delivery. Maham A; Tang Z; Wu H; Wang J; Lin Y Small; 2009 Aug; 5(15):1706-21. PubMed ID: 19572330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]